- Home
- CNTX vs TRX Comparison
CNTX vs TRX Comparison
Compare CNTX & TRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CNTX
- TRX
- Stock Information
- Founded
- CNTX 2015
- TRX 1990
- Country
- CNTX United States
- TRX Canada
- Employees
- CNTX N/A
- TRX N/A
- Industry
- CNTX Biotechnology: Pharmaceutical Preparations
- TRX
- Sector
- CNTX Health Care
- TRX
- Exchange
- CNTX Nasdaq
- TRX Nasdaq
- Market Cap
- CNTX 78.0M
- TRX 90.0M
- IPO Year
- CNTX 2021
- TRX N/A
- Fundamental
- Price
- CNTX $0.58
- TRX $0.34
- Analyst Decision
- CNTX Strong Buy
- TRX Strong Buy
- Analyst Count
- CNTX 4
- TRX 1
- Target Price
- CNTX $6.00
- TRX $1.50
- AVG Volume (30 Days)
- CNTX 164.6K
- TRX 353.8K
- Earning Date
- CNTX 05-07-2025
- TRX 07-22-2025
- Dividend Yield
- CNTX N/A
- TRX N/A
- EPS Growth
- CNTX N/A
- TRX N/A
- EPS
- CNTX N/A
- TRX N/A
- Revenue
- CNTX N/A
- TRX $45,405,000.00
- Revenue This Year
- CNTX N/A
- TRX $51.45
- Revenue Next Year
- CNTX N/A
- TRX $26.19
- P/E Ratio
- CNTX N/A
- TRX N/A
- Revenue Growth
- CNTX N/A
- TRX 26.50
- 52 Week Low
- CNTX $0.49
- TRX $0.27
- 52 Week High
- CNTX $2.75
- TRX $0.49
- Technical
- Relative Strength Index (RSI)
- CNTX 33.91
- TRX 61.19
- Support Level
- CNTX $0.49
- TRX $0.30
- Resistance Level
- CNTX $0.71
- TRX $0.35
- Average True Range (ATR)
- CNTX 0.08
- TRX 0.01
- MACD
- CNTX -0.02
- TRX 0.00
- Stochastic Oscillator
- CNTX 33.31
- TRX 80.20
About CNTX Context Therapeutics Inc.
Context Therapeutics Inc is a clinical-stage biopharmaceutical company advancing medicines for solid tumors. The development team is advancing a pipeline of various therapies with a primary focus on treating female, hormone-dependent cancer, including breast, ovarian, and endometrial cancer. The company's preclinical program, CTIM-76, is an anti-Claudin 6 (CLDN6) x anti-CD3 bispecific antibody (bsAb) that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6.
About TRX TRX Gold Corporation
TRX Gold Corp is a mineral resource company. It is engaged in the acquisition of interests and the exploration of natural resource properties. Its mineral properties are located in the United Republic of Tanzania. The company's main area of interest has been in the exploration and development of gold properties. It is focused on the Buckreef Gold Project which comprises five prospects, namely Buckreef, Bingwa, Tembo, Eastern Porphyry, and Buziba.